Global High Pressure Angiography Syringe Market Research Report 2022

As an auxiliary equipment in the radiology diagnosis and treatment system, the high-pressure injector is gradually applied in clinical with the development of X-ray, rapid film changer, image intensifier and artificial contrast agent. The basic function of the high-pressure syringe is to inject a sufficient amount of high-concentration X-ray contrast agent into the examination site quickly and accurately through percutaneous puncture into the blood vessel or through the original orifice of the human body within a certain period of time, which can diagnose the lesion. Angiography and treatment.
Due to the COVID-19 pandemic, the global High Pressure Angiography Syringe market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe High Pressure Angiography Syringe market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe High Pressure Angiography Syringe landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Below 100 ml accounting for % of the High Pressure Angiography Syringe global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of High Pressure Angiography Syringe include MASTECH, Bayer, Guerbet, Medtron AG, Siemens Healthineers, ANTMED, Hawkmed, Shengwen Pukang Medical Equipment and Jiangxi Baoeran Biomedical Technology, etc. In terms of revenue, the global 3 largest players have a % market share of High Pressure Angiography Syringe in 2021.
This report focuses on High Pressure Angiography Syringe volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall High Pressure Angiography Syringe market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global High Pressure Angiography Syringe Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Below 100 ml
100 ml-200 ml
Above 200 ml
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
MASTECH
Bayer
Guerbet
Medtron AG
Siemens Healthineers
ANTMED
Hawkmed
Shengwen Pukang Medical Equipment
Jiangxi Baoeran Biomedical Technology
Shenzhen Security Medical Products
Seacrown
Jiangxi Hongda Medical Equipment
Unionmed
Changchun Medical Polymer
Jiangsu Kangle Medical Equipment
Shenzhen Shunmei Medical